Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03106610
Title Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

bladder urothelial carcinoma

prostatic urethra urothelial carcinoma

bladder carcinoma in situ

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.